NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/21/2023
Back to search
Official data from USPTO
APEX BIOTECHNOLOGY CORP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/21/2023
Classification
Registered
Trademark type
Combined
Nice classes
5, 10
Filing date
11/01/2000
Registration date
06/03/2003
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2023
Last transaction
03/21/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
08/13/1999
First use in commerce
2000-06-00
Drawing code
3
Owner type
03
Owner location
Hsinchu, TW
Examiner
FLETCHER, TRACY L
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Apex Biotechnology Corp.
Representatives
Rebecca Liebowitz VENABLE LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagent strips for medical diagnostic use; glucose control solution for medical diagnostic use; uric acid control solution for medical diagnostic use
Class 10
blood uric acid monitoring apparatus for medical diagnostic use; blood glucose monitoring apparatus for medical diagnostic use; puncturers for medical uselancets
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/21/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/21/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
09/07/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
04/30/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/30/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/30/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/30/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
04/10/2013
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
10/23/2009
15AF
REGISTERED - SEC. 15 AFFIDAVIT FILED
10/19/2009
PAPER RECEIVED
10/19/2009
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/09/2009
PLGL
ASSIGNED TO PARALEGAL
07/09/2009
TMBN
TTAB RELEASE CASE TO TRADEMARKS
05/29/2009
CANT
CANCELLATION TERMINATED NO. 999999
05/29/2009
CAND
CANCELLATION DENIED NO. 999999
05/29/2009
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
05/11/2009
PAPER RECEIVED
05/11/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/26/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/26/2008
PETC
CANCELLATION INSTITUTED NO. 999999
06/04/2008
CFIT
CASE FILE IN TICRS
02/12/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
06/03/2003
PUBO
PUBLISHED FOR OPPOSITION
03/11/2003
NPUB
NOTICE OF PUBLICATION
02/19/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/14/2003
CNSL
LETTER OF SUSPENSION MAILED
05/16/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/09/2001
CNRT
NON-FINAL ACTION MAILED
04/09/2001
DOCK
ASSIGNED TO EXAMINER
03/16/2001
Continuous trademark protection
Get notified about every new filing that threatens APEX BIOTECHNOLOGY CORP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.